Literature DB >> 25804726

[Catecholamines: pro and contra].

R Riessen1, O Tschritter2, U Janssens3, M Haap4.   

Abstract

BACKGROUND: Catecholamines with vasopressor and inotropic effects are commonly used in intensive care medicine. The aim of this review is to explain some of the physiologic actions on which a catecholamine therapy is based, but also to elucidate the risks which are associated with an uncritical and excessive use of these drugs. SIDE EFFECTS: Emphasis is placed on the myocardial damage triggered by adrenergic overstimulation. There is considerable evidence that in conditions of severe heart failure, myocardial ischemia as well as cardiogenic and septic shock especially the use of catecholamines with predominant β-adrenergic effects (epinephrine, dobutamine, dopamine) can have a negative clinical impact. A simple cardiac risk marker might be a tachycardia. ADMINISTRATION: Vasopressor therapy with norepinephrine, based on individually applied perfusion parameters (e.g., urine output, lactate), however, seems justified in many conditions of shock and hemodynamic instability during deep analgosedation. In terms of a cardioprotective therapy, the administration of catecholamines, however, should always be reevaluated and titrated to the minimum deemed necessary.

Entities:  

Keywords:  Biogenic monoamines; Cardiomyopathy; Intensive care medicine; Sepsis; Shock

Mesh:

Substances:

Year:  2015        PMID: 25804726     DOI: 10.1007/s00063-015-0011-5

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  70 in total

1.  Adrenaline for out of hospital cardiac arrest?

Authors:  Theresa Mariero Olasveengen
Journal:  BMJ       Date:  2013-12-10

2.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  Stephan D Fihn; Julius M Gardin; Jonathan Abrams; Kathleen Berra; James C Blankenship; Apostolos P Dallas; Pamela S Douglas; Joanne M Foody; Thomas C Gerber; Alan L Hinderliter; Spencer B King; Paul D Kligfield; Harlan M Krumholz; Raymond Y K Kwong; Michael J Lim; Jane A Linderbaum; Michael J Mack; Mark A Munger; Richard L Prager; Joseph F Sabik; Leslee J Shaw; Joanna D Sikkema; Craig R Smith; Sidney C Smith; John A Spertus; Sankey V Williams
Journal:  Circulation       Date:  2012-11-19       Impact factor: 29.690

3.  Is the panic about beta-blockers in perioperative care justified?

Authors:  Thomas F Lüscher; Bernard Gersh; Ulf Landmesser; Frank Ruschitzka
Journal:  Eur Heart J       Date:  2014-02-06       Impact factor: 29.983

Review 4.  Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.

Authors:  Susanne Unverzagt; Lisa Wachsmuth; Katharina Hirsch; Holger Thiele; Michael Buerke; Johannes Haerting; Karl Werdan; Roland Prondzinsky
Journal:  Cochrane Database Syst Rev       Date:  2014-01-02

5.  Comparison of epinephrine and norepinephrine in the treatment of asphyxial or fibrillatory cardiac arrest in a porcine model.

Authors:  K H Lindner; F W Ahnefeld
Journal:  Crit Care Med       Date:  1989-05       Impact factor: 7.598

6.  Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery.

Authors:  Martin J London; Kwan Hur; Gregory G Schwartz; William G Henderson
Journal:  JAMA       Date:  2013-04-24       Impact factor: 56.272

7.  Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.

Authors:  Djillali Annane; Philippe Vignon; Alain Renault; Pierre-Edouard Bollaert; Claire Charpentier; Claude Martin; Gilles Troché; Jean-Damien Ricard; Gérard Nitenberg; Laurent Papazian; Elie Azoulay; Eric Bellissant
Journal:  Lancet       Date:  2007-08-25       Impact factor: 79.321

Review 8.  Adrenergic nervous system in heart failure: pathophysiology and therapy.

Authors:  Anastasios Lymperopoulos; Giuseppe Rengo; Walter J Koch
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

9.  Time to administration of epinephrine and outcome after in-hospital cardiac arrest with non-shockable rhythms: retrospective analysis of large in-hospital data registry.

Authors:  Michael W Donnino; Justin D Salciccioli; Michael D Howell; Michael N Cocchi; Brandon Giberson; Katherine Berg; Shiva Gautam; Clifton Callaway
Journal:  BMJ       Date:  2014-05-20

10.  Evaluation of pre-hospital administration of adrenaline (epinephrine) by emergency medical services for patients with out of hospital cardiac arrest in Japan: controlled propensity matched retrospective cohort study.

Authors:  Shinji Nakahara; Jun Tomio; Hideto Takahashi; Masao Ichikawa; Masamichi Nishida; Naoto Morimura; Tetsuya Sakamoto
Journal:  BMJ       Date:  2013-12-10
View more
  3 in total

1.  [Levosimendan-no effect on multiorgan failure in septic shock].

Authors:  U Janssens
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-01-20       Impact factor: 0.840

2.  [More negative than positive effects: adrenaline for cardiogenic shock].

Authors:  Uwe Janssens
Journal:  Med Klin Intensivmed Notfmed       Date:  2018-08-03       Impact factor: 0.840

3.  Multivalent stimulation of β1-, but not β2-receptors by adrenaline functionalised gold nanoparticles.

Authors:  Annabelle Mattern; Rebecca Claßen; Annemarie Wolf; Ervice Pouokam; Klaus-Dieter Schlüter; Mathias S Wickleder; Martin Diener
Journal:  Nanoscale Adv       Date:  2022-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.